Learn about the Bosentan REMS (Risk Evaluation and Mitigation Strategy) Program

TRACLEER is a medicine called an endothelin receptor antagonist (ERA). An ERA is a medication that helps PAH patients by blocking the effects of the extra endothelin their bodies …

Tracleer is an endothelin receptor antagonist indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1): • in adults to improve exercise ability and to decrease …

Prescribing TRACLEER through the Bosentan Risk Evaluation and Mitigation Strategy (REMS) Program

The safe use of TRACLEER requires ongoing monthly monitoring of liver function test (LFT) results and, if applicable, pregnancy test results. You must counsel your patients about the …

Initiate TRACLEER in females of reproductive potential only after a negative pregnancy test and only in females who are using two reliable methods of contraception. Females who have had …

Visit JanssenCarePath.com/Tracleer. Need help? Call a Janssen CarePath Care Coordinator at 866-228-3546, Monday–Friday, 8:00 AM to 8:00 PM ET.

TRACLEER is indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) in pediatric patients aged 3 years and older with idiopathic or congenital PAH to improve …

Janssen CarePath helps verify insurance coverage for your patients, helps find financial assistance options for eligible patients, and provides ongoing support to help patients start and …

Do Not Sell My Personal Information. THIS SITE IS INTENDED FOR U.S. AUDIENCES ONLY. © Actelion Pharmaceuticals US, Inc. 2024 04/24 cp-116018v5